Obesity

Obesity is a chronic, relapsing medical condition in which excess body fat accumulates to a degree that can harm health. It is recognized as a disease in its own right — not a failure of willpower — and is driven by a complex mix of biology, environment, and behavior, which is also why it usually responds best to long-term medical treatment rather than short-term dieting.

What is obesity?

Obesity is defined by the presence of excess body fat (adiposity) sufficient to raise the risk of, or directly cause, health problems. In adults it is most commonly screened for using body mass index (BMI) — weight in kilograms divided by height in meters squared. By the standard cutoffs, a BMI of 30.0 kg/m² or higher is classified as obesity, and a BMI of 40.0 kg/m² or higher is classified as severe (sometimes called "class III") obesity (CDC).

BMI is a screening tool, not a perfect measure of fat. It does not distinguish muscle from fat, and it can misclassify very muscular people or, conversely, miss harmful fat in people of "normal" weight. For this reason, modern frameworks increasingly pair BMI with direct measures of body shape and fat distribution. In January 2025, a global Lancet Diabetes & Endocrinology Commission proposed distinguishing "clinical obesity" — excess adiposity that is already causing organ dysfunction or limiting daily activities — from "preclinical obesity," where excess fat is present and raises future risk but has not yet produced illness. The Commission recommended confirming excess fat with at least one additional measure such as waist circumference, waist-to-hip ratio, or waist-to-height ratio, rather than relying on BMI alone (Lancet, 2025).

Obesity is one of the most common chronic conditions in the United States. CDC surveillance data show that every U.S. state and territory has an adult obesity prevalence of at least 25%, and that prevalence reaches 40% or higher in some states (CDC). In coding terms, obesity is captured under ICD-10 code E66, with subcodes such as E66.01 (morbid/severe obesity due to excess calories) and E66.9 (obesity, unspecified).

It is important to frame obesity accurately: major medical bodies, including the American Medical Association, classify it as a disease influenced by hormones, genetics, the brain's appetite-regulation systems, and the food and activity environment — not simply as a lifestyle choice.

What causes obesity, and who is at risk?

At the simplest level, obesity develops when energy intake chronically exceeds energy expenditure, and the surplus is stored as fat. But that "calories in, calories out" description hides a great deal of biology. The body defends a fairly high "set point" of fat mass through powerful hormonal and brain signals (including leptin, ghrelin, insulin, and GLP-1), which is part of why weight that is lost is so often regained (NIH; StatPearls).

Contributing factors and risk groups include:

• Genetics and family history. Heritable factors strongly influence appetite, metabolism, and where fat is stored. Rare single-gene and syndromic causes (such as leptin-pathway mutations or Prader-Willi syndrome) exist but account for a small minority of cases.
• Diet and the food environment. Diets high in calorie-dense, ultra-processed foods, added sugars, and sugar-sweetened beverages promote weight gain, as does easy, low-cost access to large portions.
• Physical inactivity and sedentary time.
• Sleep and circadian disruption. Short or poor-quality sleep and shift work are associated with weight gain.
• Chronic stress, which raises cortisol and can drive overeating.
• Certain medications, including some antipsychotics, antidepressants, corticosteroids, insulin and certain other diabetes drugs, anti-seizure medicines, and some beta-blockers.
• Medical conditions such as hypothyroidism, Cushing's syndrome, and polycystic ovary syndrome (PCOS).
• Age, pregnancy, and life transitions, including menopause, which shifts fat toward the abdomen.
• Social and economic factors — income, neighborhood food access, and education — that shape diet and activity (CDC).

Where fat is stored matters as much as how much there is. Visceral fat packed around the abdominal organs is more metabolically harmful than fat under the skin, which is why waist circumference is a useful complement to BMI. Risk also varies by ancestry: some populations, including many of South Asian descent, carry higher metabolic risk at lower BMIs.

What are the symptoms of obesity?

Obesity itself is identified by body measurements rather than by a single symptom, and many people with obesity feel well. When symptoms occur, they often reflect the mechanical load of excess weight or the metabolic strain it places on the body:

• Breathlessness or reduced exercise tolerance with everyday exertion
• Joint pain, especially in the knees, hips, and lower back (osteoarthritis)
• Excessive daytime sleepiness, loud snoring, or witnessed pauses in breathing during sleep (signs of obstructive sleep apnea)
• Fatigue and low energy
• Increased sweating and heat intolerance
• Skin changes such as acanthosis nigricans (velvety dark patches in skin folds, a sign of insulin resistance), skin-fold irritation, or rashes
• Acid reflux
• In many people, distress, low self-esteem, anxiety, or depression — driven in part by weight stigma

The greater concern is what obesity does over time. It is a major driver of type 2 diabetes, high blood pressure, high cholesterol, heart disease and stroke, obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), osteoarthritis, gallstones, certain cancers, and fertility problems (CDC; NIH).

How is obesity diagnosed?

Diagnosis begins with a clinical assessment, not a number in isolation. A clinician typically:

• Measures height and weight to calculate BMI. A BMI of 25.0–29.9 kg/m² is classified as overweight and 30.0 or above as obesity, with severe obesity at 40.0 or above (CDC). In children and teens, obesity is defined using age- and sex-specific BMI percentiles (at or above the 95th percentile) rather than fixed cutoffs.
• Measures waist circumference as an indicator of abdominal (visceral) fat, which independently raises cardiometabolic risk. The Lancet Commission recommends pairing BMI with at least one such measure (or direct fat measurement) to reduce misclassification (Lancet, 2025).
• Takes a full history of weight trajectory, diet, activity, sleep, stress, mood, medications, and family history, and screens for causes such as thyroid disease.
• Assesses for complications with blood tests — fasting glucose or HbA1c (for diabetes/prediabetes), a lipid panel, liver enzymes, and sometimes thyroid function — and checks blood pressure. Screening for obstructive sleep apnea may be appropriate.

Some specialist settings use staging systems that grade the *impact* of obesity on health (for example, the Edmonton Obesity Staging System) rather than weight alone, because two people at the same BMI can have very different risk. This is the same logic behind the clinical-versus-preclinical distinction: treatment intensity should track actual health impact, not just the scale.

How is obesity treated?

Obesity is treated as a chronic condition, meaning the goal is sustained management rather than a single "cure." Even modest weight loss of 5–10% of body weight meaningfully improves blood pressure, blood sugar, cholesterol, and sleep apnea (NIH). Care is generally layered.

Lifestyle: the foundation

Comprehensive lifestyle change is the first-line treatment and underpins every other option:

• Nutrition. A sustained reduction in calorie intake using an eating pattern the person can maintain. No single diet is uniquely best; adherence matters most.
• Physical activity. Guidelines generally recommend building toward at least 150 minutes per week of moderate activity, with resistance training to preserve muscle; more activity is especially helpful for *maintaining* lost weight.
• Behavioral support. Structured, intensive programs (self-monitoring, goal-setting, and counseling) produce the best lifestyle results.
• Sleep and stress management.

Over-the-counter options

Options here are limited. Orlistat is available over the counter in a lower dose (Alli) and works by blocking absorption of some dietary fat; its main side effects are gastrointestinal. The marketplace of unregulated "fat-burning" and herbal supplements is not supported by strong evidence, and these products are not a substitute for proven care.

Prescription medications

The FDA has approved several medications for long-term weight management, generally for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, dyslipidemia, or obstructive sleep apnea (NIDDK; FDA). Real drug classes and agents include:

• GLP-1 receptor agonists — liraglutide (Saxenda) and semaglutide (Wegovy).
• GLP-1/GIP dual agonists — tirzepatide (Zepbound).
• Phentermine-topiramate (Qsymia).
• Naltrexone-bupropion (Contrave).
• Orlistat (Xenical) at prescription strength.
• Phentermine alone, which is FDA-approved only for short-term use.

The incretin-based therapies (semaglutide and tirzepatide) generally produce the largest average weight loss and are increasingly favored when substantial reduction is needed, while orlistat, liraglutide, phentermine-topiramate, and naltrexone-bupropion may suit more moderate goals (2025 clinical guidance; EASO; WHO, 2025). The WHO's 2025 guideline recommends GLP-1 medicines for adults with obesity as part of a comprehensive program of diet, activity, and clinical support — not as a stand-alone fix. A crucial point: these are long-term treatments. Stopping them commonly leads to substantial weight regain and loss of the associated health benefits (WHO, 2025).

Surgery and devices

Metabolic and bariatric surgery (such as sleeve gastrectomy and Roux-en-Y gastric bypass) is the most effective and durable treatment for severe obesity and is typically considered at a BMI of 40 or higher, or 35 or higher with serious weight-related disease. It produces large, lasting weight loss and frequently puts type 2 diabetes into remission.

Can obesity be prevented or managed long-term?

Yes — but it requires treating obesity like the chronic condition it is. Prevention focuses on sustainable habits established early: a diet built around whole foods and limited in sugary drinks and ultra-processed foods, regular physical activity, adequate sleep, and stress management. Because the environment heavily shapes behavior, public-health measures (food labeling, school nutrition, walkable communities) also play a role (CDC).

For someone already living with obesity, long-term management means ongoing follow-up rather than a finite "diet." Weight regain is biologically expected after weight loss, which is why maintenance strategies — continued behavioral support, high physical activity, and, when prescribed, continued medication — are central. Framing weight management as lifelong care, free of blame, improves both outcomes and mental health.

When should you see a doctor?

It is reasonable to talk with a clinician any time weight is affecting health or quality of life. Seek medical attention promptly for these red flags:

• Chest pain, severe shortness of breath, or signs of a stroke (face drooping, arm weakness, speech difficulty) — call emergency services.
• Loud snoring with witnessed pauses in breathing, choking or gasping at night, or severe daytime sleepiness — possible obstructive sleep apnea.
• Symptoms of diabetes — excessive thirst, frequent urination, blurred vision, unexplained fatigue.
• Rapid or unexplained weight gain, which can signal a medication effect, hormonal disorder, or fluid retention.
• Severe or worsening joint pain limiting mobility.
• Symptoms of depression, anxiety, or thoughts of self-harm. Help is available, and in the U.S. the 988 Suicide and Crisis Lifeline can be reached by call or text.

What is the outlook (prognosis)?

The outlook for obesity is genuinely encouraging when it is treated as a chronic medical condition. Modest, sustained weight loss reduces the risk of diabetes, improves blood pressure and cholesterol, eases sleep apnea and joint pain, and improves quality of life (NIH). Modern incretin medications and bariatric surgery can produce weight loss large enough to reverse or sharply improve many complications, including putting type 2 diabetes into remission for some people.

The main challenge is durability: the body actively resists weight loss, so regain is common without ongoing support, and obesity is best understood as a relapsing condition rather than a one-time problem. People who stay engaged in long-term care — combining behavior change with medication or surgery where appropriate — tend to do far better than those who cycle through short-term diets. Importantly, treating obesity is not about appearance; it is about lowering the risk of serious disease and improving how well and how long a person lives.

Frequently asked questions

Is obesity really a disease, or just a lifestyle problem? Major medical organizations classify obesity as a chronic disease. It is shaped by genetics, hormones, the brain's appetite systems, medications, and the environment — not simply willpower. Recognizing it as a disease is part of why effective medical treatments now exist.

Is BMI a reliable way to diagnose obesity? BMI is a useful screening tool but an imperfect one. It does not measure body fat directly and can misclassify muscular or older individuals. That is why clinicians increasingly add waist circumference or other body-fat measures and assess actual health impact, as recommended by the 2025 Lancet Commission.

Will I regain the weight if I stop weight-loss medication? Frequently, yes. Anti-obesity medications such as semaglutide and tirzepatide are intended as long-term treatments; studies show that stopping them often leads to substantial weight regain (WHO, 2025). Decisions about continuing, adjusting, or stopping should be made with a clinician.

How much weight do I need to lose to improve my health? Losing as little as 5–10% of body weight can meaningfully improve blood sugar, blood pressure, cholesterol, and sleep apnea (NIH). Health benefits begin well before reaching an "ideal" weight.

Are GLP-1 medications safe? For appropriately selected patients they are generally well tolerated, with nausea and other gastrointestinal effects being the most common side effects. They are not suitable for everyone, and a clinician will review your history, including thyroid and pancreatic risk factors, before prescribing.